Frontiers in Pharmacology | Pharmacology of Anti-Cancer Drugs

Review

Published on 30 Apr 2025

Nanotechnology-driven strategies in postoperative cancer treatment: innovations in drug delivery systems

in Pharmacology of Anti-Cancer Drugs

Jun-Jie Zhou
Yan-Chuan Feng
Min-Long Zhao
Qi Guo
Xi-Bo Zhao

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1586948

1,076 views

Original Research

Published on 30 Apr 2025

Sulindac exhibits anti-proliferative and anti-invasive effects and enhances the sensitivity to paclitaxel in ovarian cancer

in Pharmacology of Anti-Cancer Drugs

Shuning Chen
Weimin Kong
Xiaochang Shen
Nikita Sinha
Jennifer Haag
Boer Deng
Haomeng Zhang
Catherine John
Wenchuan Sun
Chunxiao Zhou

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1520771

1,051 views

General Commentary

Published on 30 Apr 2025

Commentary: Triclabendazole induces pyroptosis by activating caspase-3 to cleave GSDME in breast cancer cells

in Pharmacology of Anti-Cancer Drugs

Jie Guo
Wen-Long Peng
Chen-Guang Li
Yu-Long Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1583920

686 views

Case Report

Published on 29 Apr 2025

Case report: Durable response of immuno-chemotherapy targeting a rare ROS1 fusion-positive extensive-stage SCLC patient after primary resistance to crizotinib

in Pharmacology of Anti-Cancer Drugs

Mengli Qiu
Peiwen Guo
Sisi Wang
Yong Zhu
Siqi Wu
Huiting Peng
Zehuai Guo
Yanmeng Guo
Jieheng Lin
Yang Cao

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1522542

1,185 views

Original Research

Published on 29 Apr 2025

20(S)-protopanaxadiol inhibits proliferation and induces apoptosis of acute myeloid leukemia cells via targeting Bcl-XL and MCL-1

in Pharmacology of Anti-Cancer Drugs

Meng Xu
Feng Hao
Shuangshuang Wu
Zhanning Qu
Junying Li
Shuang Chen
Fang Fang
Yundong Zhao
Cheng Hu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1530270

1,058 views

Original Research

Published on 28 Apr 2025

Bioinformatics analysis across pan-cancer and experimental validation in hepatocellular carcinoma revealed the oncogenic role of SF3B6

in Pharmacology of Anti-Cancer Drugs

Linshuang Tu
Jiefu Luo
Ya Yin
Huihong Yu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1516534

1,798 views
1 citation

Editorial

Published on 28 Apr 2025

Editorial: Recent advances in understanding sex-based tumor diversity

in Pharmacology of Anti-Cancer Drugs

Swati Kushwaha
Radha Kushwaha
Prem Prakash Kushwaha

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1598740

588 views

Case Report

Published on 25 Apr 2025

Excellent efficacy of trastuzumab deruxtecan in a patient with HER2-positive advanced breast cancer complicated by pulmonary lymphangitic carcinomatosis: a case report and literature review

in Pharmacology of Anti-Cancer Drugs

Simin Luo
Jie Chai
Linxiaoxiao Ding
Song Tang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1574286

1,260 views

Systematic Review

Published on 25 Apr 2025

Global trends in resistance studies of gemcitabine and pancreatic cancer: a bibliometric and visual analysis from 2010 to 2024

in Pharmacology of Anti-Cancer Drugs

Dandan Gu
Shaoyang Huang
Kai Zhao
Xiaohong Zhang
Jinjing Zhang
Wei Xiong

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1564561

1,671 views

Review

Published on 25 Apr 2025

Studies on the mechanism of ototoxic action of cisplatin and the antagonistic effect of polyphenolic compounds

in Pharmacology of Anti-Cancer Drugs

Shengyu Han
Jinjun Sun
Wenpeng Li
Jihong Li
Haoming Yu
Shuai Wang
Yuhua Chi

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1586243

1,611 views

Original Research

Published on 25 Apr 2025

The mechanistic study of codonopsis pilosula on laryngeal squamous cell carcinoma based on network pharmacology and experimental validation

in Pharmacology of Anti-Cancer Drugs

Huina Guo
Yichen Lou
Xiaofang Hou
Xiaoya Guan
Yujia Guo
Qi Han
Xuting Xue
Ying Wang
Long He
Zhongxun Li

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1542116

1,498 views

Case Report

Published on 25 Apr 2025

Case report: Transformative potential of trastuzumab deruxtecan in the first line treatment for advanced HER2-mutated lung adenocarcinoma: a case report and clinical insights

in Pharmacology of Anti-Cancer Drugs

Guanbin Huang
Tongtong Xia
Dongxiao Yang
Muwen Lin
Yiping Luo
Yuchan Li
Hualin Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1564834

1,597 views

Mini Review

Published on 24 Apr 2025

Research progress on ferroptosis and PARP inhibitors in ovarian cancer: action mechanisms and resistance mechanisms

in Pharmacology of Anti-Cancer Drugs

Jiqing Zhang
Dan Ouyang
Mu Liu
Yuting Xiang
Zhongjun Li

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1598279

1,996 views
1 citation

Original Research

Published on 24 Apr 2025

Bioactive natural alkaloid 6−Methoxydihydrosanguinarine exerts anti−tumor effects in hepatocellular carcinoma cells via ferroptosis

in Pharmacology of Anti-Cancer Drugs

Linfen Han
Chengchang Gao
Xiaorui Jin
Yingping Li
Liangjie Chen
Donglin Li
Qinqin Deng
Xueli Bian

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1500461

1,254 views

Correction

Published on 23 Apr 2025

Corrigendum: Synthesis, characterization, and computational evaluation of some synthesized xanthone derivatives: focus on kinase target network and biomedical properties

in Pharmacology of Anti-Cancer Drugs

Wisam Taher Muslim
Layth Jasim Mohammad
Munaf M. Naji
Isaac Karimi
Matheel D. Al-Sabti
Majid Jabir
Mazin A. A. Najm
Helgi B. Schiöth

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1583894

670 views

Original Research

Published on 22 Apr 2025

Adverse reactions of four multi-targeted tyrosine kinase inhibitors: a descriptive analysis of the WHO-VigiAccess database

in Pharmacology of Anti-Cancer Drugs

Lijun Li
Jiayu Bai
Xuelong Wen
Xuefan Zeng

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1585862

1,130 views